Moloney Securities Asset Management, LLC Biogen Inc. Transaction History

Moloney Securities Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$190.52 - $236.72 $26,672 - $33,140	140 Added 10.02%	1,537 $356,000
Q1 2024 May 01, 2024	BUY	$212.02 - $267.71 $296,191 - $373,990	1,397 New	1,397 $301,000
Q1 2018 Apr 25, 2018	SELL	$260.13 - $367.91 $193,536 - $273,725	-744 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$281.15 - $329.69 $209,175 - $245,289	744	744 $233,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.